| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Kexin Xu
|
|||||||
| GSE80238 |
Gemone-wide changes of epigenetic mark H3K27 trimethylation (H3K27me3) and AR in prostate cancer cells upon the treatment of EZH2 inhibitors [ChIP-seq]
|
9 | Kexin Xu | Sep 01, 2017 | ||||
| GSE80239 |
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq]
|
12 | Kexin Xu | Sep 01, 2017 | ||||
| GSE80240 |
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells
|
21 | Kexin Xu | Sep 01, 2017 | ||||
| GSE67809 |
Genome-wide chromatin binding of transcription factor E2F1 in castration resistant prostate cancer (CRPC) cells
|
2 | Kexin Xu | Apr 14, 2015 | ||||
| GSE39452 |
Expression data of EZH2-dependent genes in prostate cancer cell lines
|
12 | Kexin Xu | Nov 30, 2012 | ||||
| GSE39459 |
Genome-wide maps of PRC2 complex components and chromatin states in prostate cancer cell lines
|
12 | Kexin Xu | Nov 30, 2012 | ||||
| GSE39461 |
Role of PRC2 complex components in prostate cancer cell lines
|
24 | Kexin Xu | Nov 30, 2012 |
